Analyst Price Targets — OLPX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 12:54 pm | — | Barclays | $2.00 | $2.02 | TheFly | Olaplex price target raised to $2 from $1.75 at Barclays |
| March 27, 2026 2:04 pm | — | Telsey Advisory | $2.06 | $2.02 | TheFly | Olaplex price target raised to $2.06 from $2 at Telsey Advisory |
| March 10, 2026 7:52 pm | Dara Mohsenian | Morgan Stanley | $1.40 | $1.30 | StreetInsider | Morgan Stanley Reiterates Equalweight Rating on Olaplex Inc (OLPX): "turnaround is still a work in progress" |
| March 6, 2026 1:37 pm | Robert Ottenstein | Evercore ISI | $2.50 | $1.37 | StreetInsider | Olaplex Inc (OLPX) PT Lowered to $2.50 at Evercore ISI |
| January 16, 2026 3:10 pm | — | Barclays | $1.75 | $1.61 | TheFly | Olaplex price target raised to $1.75 from $1.25 at Barclays |
| January 14, 2026 11:27 am | — | Jefferies | $1.50 | $1.65 | TheFly | Olaplex assumed with a Hold at Jefferies |
| November 20, 2025 2:05 pm | — | Northland Securities | $2.00 | $1.10 | TheFly | Olaplex initiated with an Outperform at Northland |
| August 25, 2025 8:37 am | — | Canaccord Genuity | $2.00 | $1.54 | TheFly | Olaplex upgraded to Buy from Hold at Canaccord |
| July 15, 2025 11:25 am | Lauren Lieberman | Barclays | $1.50 | $1.51 | TheFly | Olaplex Holdings price target raised to $1.50 from $1.40 at Barclays |
| March 5, 2025 10:15 am | — | Barclays | $1.70 | $1.63 | TheFly | Olaplex Holdings price target raised to $1.70 from $1.50 at Barclays |
Latest News for OLPX
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Olaplex (NASDAQ: OLPX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Henkel.
Alto Ingredients (NASDAQ: ALTO - Get Free Report) and Olaplex (NASDAQ: OLPX - Get Free Report) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Analyst Ratings This is a breakdown of
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. Under the terms of the proposed transaction, shareholders of Olaplex will receive $2.06 in cash for each share of Olaplex that they own. KSF is seeking to…
BALA CYNWYD, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Olaplex Holdings, Inc. (“Olaplex” or the “Company”) (Nasdaq - OLPX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Henkel AG & Co. KGaA (“Henkel”) for $2.06 per…
Foxx Development (NASDAQ: FOXX - Get Free Report) and Olaplex (NASDAQ: OLPX - Get Free Report) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends. Insider and Institutional Ownership 60.4% of Foxx
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OLPX.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.